Dn B Asset Management As Eli Lilly & CO Transaction History

Dn B Asset Management As

$19.9 Billion
Q2 2024

A detailed history of Dn B Asset Management As transactions in Eli Lilly & CO stock. As of the latest transaction made, Dn B Asset Management As holds 360,192 shares of LLY stock, worth $319 Million. This represents 1.64% of its overall portfolio holdings.

Number of Shares

360,192

Previous 342,133 5.28%

Holding current value

$319 Million

Previous $266 Million 22.52%

% of portfolio

1.64%

Previous 1.46%

28 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 05, 2024	BUY	$724.87 - $909.04 $13.1 Million - $16.4 Million	18,059 Added 5.28%	360,192 $326 Million
Q1 2024 Apr 12, 2024	SELL	$592.2 - $792.28 $27.2 Million - $36.4 Million	-45,951 Reduced 11.84%	342,133 $266 Million
Q4 2023 Jan 04, 2024	SELL	$525.19 - $619.13 $4.5 Million - $5.31 Million	-8,569 Reduced 2.16%	388,084 $226 Million
Q3 2023 Oct 13, 2023	SELL	$434.7 - $599.3 $18.4 Million - $25.4 Million	-42,369 Reduced 9.65%	396,653 $213 Million
Q2 2023 Jul 06, 2023	SELL	$350.74 - $468.98 $8.64 Million - $11.6 Million	-24,630 Reduced 5.31%	439,022 $206 Million
Q1 2023 Apr 20, 2023	SELL	$310.63 - $364.82 $2.56 Million - $3 Million	-8,233 Reduced 1.74%	463,652 $159 Million
Q4 2022 Jan 12, 2023	SELL	$321.55 - $374.67 $854,358 - $995,498	-2,657 Reduced 0.56%	471,885 $173 Billion
Q3 2022 Oct 11, 2022	SELL	$296.48 - $337.87 $1.92 Million - $2.19 Million	-6,471 Reduced 1.35%	474,542 $153 Million
Q2 2022 Jul 08, 2022	SELL	$278.73 - $327.27 $2.29 Million - $2.69 Million	-8,227 Reduced 1.68%	481,013 $156 Billion
Q1 2022 Apr 08, 2022	BUY	$234.69 - $291.66 $10.3 Million - $12.9 Million	44,083 Added 9.9%	489,240 $140 Million
Q4 2021 Jan 12, 2022	SELL	$224.85 - $279.04 $1.26 Million - $1.57 Million	-5,620 Reduced 1.25%	445,157 $123 Million
Q3 2021 Oct 15, 2021	BUY	$221.6 - $272.71 $4.32 Million - $5.32 Million	19,511 Added 4.52%	450,777 $104 Million
Q2 2021 Jul 06, 2021	BUY	$180.55 - $233.54 $41.5 Million - $53.7 Million	229,853 Added 114.12%	431,266 $99 Billion
Q1 2021 Apr 15, 2021	SELL	$164.32 - $212.72 $7.66 Million - $9.92 Million	-46,641 Reduced 18.8%	201,413 $37.6 Million
Q4 2020 Jan 19, 2021	BUY	$130.46 - $172.63 $486,224 - $643,392	3,727 Added 1.53%	248,054 $41.9 Million
Q3 2020 Oct 14, 2020	BUY	$146.22 - $169.13 $19.3 Million - $22.3 Million	132,052 Added 117.61%	244,327 $36.2 Million
Q2 2020 Jul 08, 2020	BUY	$136.42 - $164.18 $2.34 Million - $2.81 Million	17,118 Added 17.99%	112,275 $18.4 Billion
Q1 2020 Apr 17, 2020	SELL	$119.05 - $147.35 $10.3 Million - $12.8 Million	-86,888 Reduced 47.73%	95,157 $13.2 Million
Q4 2019 Jan 13, 2020	SELL	$106.92 - $132.43 $5.65 Million - $7 Million	-52,842 Reduced 22.5%	182,045 $23.9 Million
Q3 2019 Oct 16, 2019	BUY	$106.79 - $116.16 $948,508 - $1.03 Million	8,882 Added 3.93%	234,887 $26.3 Million
Q2 2019 Jul 08, 2019	BUY	$110.79 - $129.32 $2.56 Million - $2.99 Million	23,122 Added 11.4%	226,005 $0
Q1 2019 Apr 11, 2019	SELL	$111.31 - $131.02 $29.3 Million - $34.5 Million	-263,305 Reduced 56.48%	202,883 $0
Q4 2018 Jan 15, 2019	SELL	$105.9 - $118.64 $49.7 Million - $55.7 Million	-469,218 Reduced 50.16%	466,188 $53.9 Million
Q3 2018 Oct 10, 2018	SELL	$85.86 - $107.31 $2.24 Million - $2.8 Million	-26,092 Reduced 2.71%	935,406 $0
Q2 2018 Jul 06, 2018	BUY	$75.7 - $86.88 $45.7 Million - $52.5 Million	604,200 Added 169.1%	961,498 $0
Q1 2018 Apr 11, 2018	BUY	$74.21 - $87.6 $9.19 Million - $10.9 Million	123,900 Added 53.09%	357,298 $0
Q4 2017 Jan 10, 2018	SELL	$81.94 - $87.89 $5.61 Million - $6.02 Million	-68,452 Reduced 22.68%	233,398 $0
Q3 2017 Oct 11, 2017	BUY	$77.07 - $85.54 $23.3 Million - $25.8 Million	301,850	301,850 $0

Others Institutions Holding LLY

# of Institutions

3,871

Shares Held

751M

Call Options Held

6.34M

Put Options Held

7.97M

View Full List

About ELI LILLY & Co

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $843B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

More about LLY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Dn B Asset Management As, based on Form 13F filings with the SEC.

News

Stay updated on Dn B Asset Management As with notifications on news.

Account

Dn B Asset Management As Eli Lilly & CO Transaction History